Sivan Harel

Sivan Harel currently serves as the Director of Translational Biomarkers & Bioanalytics at Chroma Medicine, beginning in September 2023. Prior experience includes a role as Director of Translational Sciences at eGenesis, Inc., where Sivan established a team focused on clinical assay development and biomarker discovery for organ transplantation studies, while also contributing to regulatory strategies. Previous positions at Regeneron involved leading translational and biomarker efforts for the FDA-approved drug Dupixent and developing biomarker discovery platforms. Additional experience includes significant roles in both research and management related to autoimmune diseases and molecular biology. Sivan holds a Ph.D. in Molecular Biology from Columbia University and a B.A. in Molecular Biology from the University of California, Berkeley.